Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMAD3 antisense RNA 1 (SMAD3-AS1)
- Target
- SMAD3-AS1
- Molecular classification
- Long non-coding RNA, Natural antisense transcript
01
Overview
SMAD3 antisense RNA 1 (SMAD3-AS1), also known as AC012568.1, is a long non-coding RNA annotated as a natural antisense transcript of the SMAD3 gene. Like other antisense lncRNAs, it is transcribed from the opposite strand of its partner protein-coding gene (SMAD3). While natural antisense transcripts can regulate gene expression through epigenetic, transcriptional, or post-transcriptional mechanisms, there are currently no published functional studies describing the specific role or biological impact of SMAD3-AS1. It is not considered a canonical therapeutic target, and no drugs or therapeutics are reported to act on this molecule.
- Other names
- AC012568.1SMAD3-AS1
02
Biological functions
Other (Potential gene regulation via antisense mechanisms, but specific regulatory functions for SMAD3-AS1 are not well-established in the literature)
03
Disease associations
Other (No direct evidence for a role in major diseases such as cancer, inflammation, etc.; research on related SMAD antisense lncRNAs exists but not for this specific transcript)
Beyond the preview
Go deeper on SMAD3 antisense RNA 1 (SMAD3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SMAD3 antisense RNA 1 (SMAD3-AS1).